STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States
STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S.Approved for the same indications as the reference product, STEQEYMA will be priced with a wholesale acquisition